Price target upside
Arcutis Biotherapeutics, Inc. Price Target Upside or Downside
ARQT price target upside based on the current price and analyst average.
Direct answer
Arcutis Biotherapeutics, Inc.'s analyst target implies +40.6%.
The average target is $36.88 compared with a recorded current price of $26.23.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Arcutis Biotherapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $26.23
- Average price target
- $36.88
- High price target
- $40.00
- Low price target
- $34.00
- Target upside
- +40.6%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026